These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 21741479)
1. Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts. Aldakkak M; Camara AK; Heisner JS; Yang M; Stowe DF Pharmacol Res; 2011 Oct; 64(4):381-92. PubMed ID: 21741479 [TBL] [Abstract][Full Text] [Related]
2. Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine. Gadicherla AK; Stowe DF; Antholine WE; Yang M; Camara AK Biochim Biophys Acta; 2012 Mar; 1817(3):419-29. PubMed ID: 22178605 [TBL] [Abstract][Full Text] [Related]
3. Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion. Dehina L; Descotes J; Chevalier P; Bui-Xuan B; Romestaing C; Dizerens N; Mamou Z; Timour Q Fundam Clin Pharmacol; 2014 Jun; 28(3):257-67. PubMed ID: 23607936 [TBL] [Abstract][Full Text] [Related]
5. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190 [TBL] [Abstract][Full Text] [Related]
6. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025 [TBL] [Abstract][Full Text] [Related]
7. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange. Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384 [TBL] [Abstract][Full Text] [Related]
8. Reduced mitochondrial Ca2+ loading and improved functional recovery after ischemia-reperfusion injury in old vs. young guinea pig hearts. Rhodes SS; Camara AK; Heisner JS; Riess ML; Aldakkak M; Stowe DF Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H855-63. PubMed ID: 22140052 [TBL] [Abstract][Full Text] [Related]
9. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Gralinski MR; Black SC; Kilgore KS; Chou AY; McCormack JG; Lucchesi BR Cardiovasc Res; 1994 Aug; 28(8):1231-7. PubMed ID: 7954626 [TBL] [Abstract][Full Text] [Related]
11. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel. Hale SL; Leeka JA; Kloner RA J Pharmacol Exp Ther; 2006 Jul; 318(1):418-23. PubMed ID: 16617168 [TBL] [Abstract][Full Text] [Related]
12. Hypothermia Prevents Cardiac Dysfunction during Acute Ischemia Reperfusion by Maintaining Mitochondrial Bioenergetics and by Promoting Hexokinase II Binding to Mitochondria. Sun J; Mishra J; Yang M; Stowe DF; Heisner JS; An J; Kwok WM; Camara AKS Oxid Med Cell Longev; 2022; 2022():4476448. PubMed ID: 35873800 [TBL] [Abstract][Full Text] [Related]
13. Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. An J; Varadarajan SG; Camara A; Chen Q; Novalija E; Gross GJ; Stowe DF Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2398-409. PubMed ID: 11709405 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429 [TBL] [Abstract][Full Text] [Related]
15. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related]
16. Changes in [Na(+)](i), compartmental [Ca(2+)], and NADH with dysfunction after global ischemia in intact hearts. Varadarajan SG; An J; Novalija E; Smart SC; Stowe DF Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H280-93. PubMed ID: 11123243 [TBL] [Abstract][Full Text] [Related]
17. Effect of low [CaCl2] and high [MgCl2] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts. An J; Camara AK; Chen Q; Stowe DF Eur J Cardiothorac Surg; 2003 Dec; 24(6):974-85. PubMed ID: 14643817 [TBL] [Abstract][Full Text] [Related]
18. Modulation of mitochondrial bioenergetics in the isolated Guinea pig beating heart by potassium and lidocaine cardioplegia: implications for cardioprotection. Aldakkak M; Stowe DF; Lesnefsky EJ; Heisner JS; Chen Q; Camara AK J Cardiovasc Pharmacol; 2009 Oct; 54(4):298-309. PubMed ID: 19620879 [TBL] [Abstract][Full Text] [Related]
19. Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts. Nazari A; Sadr SS; Faghihi M; Azizi Y; Hosseini MJ; Mobarra N; Tavakoli A; Imani A Eur J Pharmacol; 2015 Aug; 760():96-102. PubMed ID: 25895639 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Na+/H+ exchange during ischemia and reperfusion impairs mitochondrial bioenergetics and myocardial function. Aldakkak M; Stowe DF; Heisner JS; Spence M; Camara AK J Cardiovasc Pharmacol; 2008 Sep; 52(3):236-44. PubMed ID: 18806604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]